Wounding sheets of epithelial cells activates the epidermal growth factor receptor through distinct short- and long-range mechanisms.
Wounding epithelia induces activation of the epidermal growth factor receptor (EGFR), which is absolutely required for induction of motility. ATP is released from cells after wounding; it binds to purinergic receptors on the cell surface, and the EGFR is subsequently activated. Exogenous ATP activates phospholipase D, and we show here that ATP activates the EGFR through the phospholipase D2 isoform. The EGFR is activated in cells far (>0.3 cm) from wounds, which is mediated by diffusion of extracellular ATP because activation at a distance from wounds is abrogated by eliminating ATP in the medium with apyrase. In sharp contrast, activation of the EGFR near wounds is not sensitive to apyrase. Time-lapse microscopy revealed that cells exhibit increased motilities near edges of wounds; this increase in motility is not sensitive to apyrase, and apyrase does not detectably inhibit healing of wounds in epithelial sheets. This novel ATP/PLD2-independent pathway activates the EGFR by a transactivation process through ligand release, and it involves signaling by a member of the Src family of kinases. We conclude that wounding activates two distinct signaling pathways that induce EGFR activation and promote healing of wounds in epithelial cells. One pathway signals at a distance from wounds through release of ATP, and another pathway acts locally and is independent on ATP signaling.
Block
Ethan R
ER
Ophthalmology and Visual Sciences Research Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Klarlund
Jes K
JK
D000255:Adenosine Triphosphate / Q000378:metabolism; D002460:Cell Line; D004789:Enzyme Activation; D004847:Epithelial Cells / Q000201:enzymology* / Q000473:pathology*; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D005110:Extracellular Space / Q000378:metabolism; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D016850:Limbus Corneae / Q000166:cytology; D008954:Models, Biological; D010739:Phospholipase D / Q000378:metabolism; D015398:Signal Transduction; D015533:Transcriptional Activation; D014945:Wound Healing; D019061:src-Family Kinases / Q000378:metabolism
D007527:Isoenzymes; D000255:Adenosine Triphosphate; D066246:ErbB Receptors; D019061:src-Family Kinases; D048049:Extracellular Signal-Regulated MAP Kinases; C105606:phospholipase D2; D010739:Phospholipase D
Biochem Cell Biol. 2004 Feb;82(1):225-53
15052340
Cell Mol Life Sci. 2007 Jun;64(12):1471-83
17375261
Cancer Res. 2004 Sep 1;64(17):6166-73
15342401
J Cell Sci. 2007 Mar 1;120(Pt 5):876-84
17298977
J Cell Biochem. 2004 Dec 15;93(6):1115-33
15449317
Kidney Int. 1995 Jul;48(1):85-92
7564096
Mol Cell Biol. 2003 May;23(9):3103-15
12697812
Invest Ophthalmol Vis Sci. 2004 Mar;45(3):813-20
14985295
Cornea. 2005 Jul;24(5):509-22
15968154
C R Biol. 2002 May;325(5):557-64
12187641
J Cell Sci. 2007 Mar 1;120(Pt 5):815-25
17284517
Am J Physiol Cell Physiol. 2006 Jul;291(1):C1-10
16769815
Biochem Soc Trans. 2003 Dec;31(Pt 6):1203-8
14641026
J Biol Chem. 2004 Apr 23;279(17):16918-26
14761980
Growth Factors. 2006 Jun;24(2):121-36
16801132
Cornea. 2005 Nov;24(8 Suppl):S2-S11
16227819
Endocrinology. 1990 Sep;127(3):1436-43
1696885
J Neurochem. 1999 Jul;73(1):334-43
10386986
Curr Opin Genet Dev. 2005 Aug;15(4):447-53
15950458
Oncogene. 2007 May 14;26(22):3113-21
17496910
Biochem Biophys Res Commun. 1989 Nov 30;165(1):319-26
2556140
Eur J Clin Invest. 1998 Jul;28(7):554-61
9726036
Front Biosci. 2007 May 01;12:2849-68
17485264
Curr Biol. 2000 Jul 13;10(14):831-8
10899000
Am J Physiol. 1992 Apr;262(4 Pt 1):C941-9
1314492
Biochem J. 1992 Jul 1;285 ( Pt 1):235-40
1637305
Biochem J. 2007 Dec 15;408(3):297-315
17850214
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2496-506
12766048
J Cell Sci. 2005 Jan 1;118(Pt 1):51-63
15585576
FEBS Lett. 2002 Oct 30;531(1):58-61
12401203
Physiol Rev. 2007 Apr;87(2):659-797
17429044
J Biol Chem. 2007 Feb 2;282(5):3213-20
17135261
Biochem Biophys Res Commun. 2005 May 27;331(1):1-14
15845350
J Biol Chem. 1992 Nov 25;267(33):23664-73
1331096
Nat Cell Biol. 2001 May;3(5):E117-23
11331897
J Cell Sci. 2001 Dec;114(Pt 23):4185-95
11739651
Novartis Found Symp. 2006;276:26-48; discussion 48-57, 275-81
16805422
Proc Natl Acad Sci U S A. 2006 May 2;103(18):6901-6
16641105
Invest Ophthalmol Vis Sci. 2000 May;41(6):1346-55
10798649
Biochem J. 1996 Jan 15;313 ( Pt 2):529-35
8573088
J Cell Biochem. 2004 Apr 1;91(5):938-50
15034929
J Mammary Gland Biol Neoplasia. 2007 Sep;12(2-3):103-14
17549611
J Immunol. 2000 Jan 1;164(1):379-88
10605033
Mol Biotechnol. 2005 Oct;31(2):151-74
16170216
J Invest Dermatol. 2004 Nov;123(5):982-9
15482488
Am J Physiol Lung Cell Mol Physiol. 2006 May;290(5):L849-55
16361356
Biochim Biophys Acta. 2007 Aug;1773(8):1161-76
17306385
Pharmacol Ther. 2006 Nov;112(2):358-404
16784779
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2832-9
16799022
J Pharmacol Exp Ther. 2005 Mar;312(3):1043-54
15525798
Exp Eye Res. 2007 Jul;85(1):130-41
17490650
IUBMB Life. 2006 Aug;58(8):457-61
16916782
Dermatol Clin. 2007 Oct;25(4):477-85, vii
17903607
Am J Pathol. 1997 Jun;150(6):1959-75
9176390
Cell Signal. 2003 Oct;15(10):927-35
12873706
J Cell Sci. 2006 Apr 15;119(Pt 8):1645-54
16569667
J Biol Chem. 2004 Jun 4;279(23):24307-12
15039441
J Lipid Res. 2002 Aug;43(8):1244-55
12177168
J Mol Biol. 1990 Oct 5;215(3):403-10
2231712
Biochim Biophys Acta. 2005 Aug 1;1751(1):110-7
16054021
Cell Mol Life Sci. 2005 Oct;62(19-20):2305-16
16143829